Image source: Cryptographer
Highlights
- FPH is an ASX-listed healthcare company which offers medical devices and technologies.
- With the easing of pandemic related restrictions, FPH’s operating revenue improved considerably in 2HFY23.
- Mitsubishi UFJ Financial Group Inc. has the maximum shareholding in the firm with a stake of around 8.27%.
Fisher & Paykel Healthcare Corporation Limited (ASX: FPH) offers medical devices and technologies which are used in acute and chronic respiratory care, surgery and treating obstructive sleep apnea. FPH’s products are sold in over 120 countries worldwide.
With the easing of pandemic-related restrictions worldwide, the company witnessed significant improvement in business in the middle of the financial year 2023 (FY23), as operating revenue increased by 14% YoY in the second half of FY23 (2HFY23).
However, in FY23, the total operating revenue dropped by 6% to NZD 1,581.1 million and net profit after tax dropped by 34% YoY to NZD 250.3 million.
The period saw new product launches and the building of infrastructure.

Top 10 shareholders of FPH
The top 10 shareholders of FPH have nearly 32.66% stake in the company, while the top four shareholders have a 21.77% stake in the firm. Mitsubishi UFJ Financial Group Inc. and Hyperion Asset Management Limited have the highest stake in FPH, with a shareholding of ~8.27% and ~5.05%, respectively.

Recent business update
Through an ASX update dated 29 August 2023, the company informed about the update in its guidance for 1HFY24. The expected range of net profit after tax is NZD 95-105 million, and expected operating revenue is around NZD 790 million.
Outlook
In FY24, the company expects to deliver revenue of circa NZD 1.70 billion. Considering the land and building programs, the expected capital expenditure in FY24 is NZD 450 million.
The company expects to report a gross margin improvement of 200 basis points in constant currency during the stated period.
Share performance of FPH
FPH shares closed 0.5% up at AUD 20.24 apiece. Including today’s gain, FPH’s shares have dropped by 16.40% in the last six months.
The 52-week high of FPH is AUD 26.08, recorded on 1 May 2023, while the 52-week low is AUD 16.11 apiece, recorded on 13 October 2022.

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.
Note 2: The reference date for all price data, currency, is 27 September 2023. The reference data in this report has been partly sourced from REFINITIV.
Disclaimer:
This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.
Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.
Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.
The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.
The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.
Kalkine does not issue, sell or deal in any financial products.
This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.
To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.
Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Copyright 2026 Krish Capital Pty. Ltd. (ABN 61629651510). All Rights Reserved. No part of this Article, or its content, may be reproduced in any form without our prior consent.